Key result
Large-scale rotavirus vaccination in Belgium led to an 85% decrease in rotavirus-related hospitalizations, with the subsequent predominance of G2P[4] infections explained by weaker immunity against heterotypic strains.
Why the study?
Does large-scale rotavirus vaccination drive changes in the circulating rotavirus genotype population in Belgium?
Does large-scale rotavirus vaccination drive changes in the circulating rotavirus genotype population in Belgium?
Mathematical modeling suggests that the shift toward the G2P[4] rotavirus genotype in Belgium following large-scale vaccination is driven by weaker heterotypic immunity, while overall hospitalizations remain substantially reduced.
Sustained rotavirus vaccination benefits persist despite G2P[4] predominance; leaves open optimal strategies for heterotypic strain coverage.
Vaccination can place selective pressures on viral populations, leading to changes in the distribution of strains as viruses evolve to escape immunity from the vaccine. Vaccine-driven strain replacement is a major concern after nationwide rotavirus vaccine introductions. However, the distribution of the predominant rotavirus genotypes varies from year to year in the absence of vaccination, making it difficult to determine what changes can be attributed to the vaccines. To gain insight in the underlying dynamics driving changes in the rotavirus population, we fitted a hierarchy of mathematical models to national and local genotype-specific hospitalization data from Belgium, where large-scale vaccination was introduced in 2006. We estimated that natural- and vaccine-derived immunity was strongest against completely homotypic strains and weakest against fully heterotypic strains, with an intermediate immunity amongst partially heterotypic strains. The predominance of G2P[4] infections in Belgium after vaccine introduction can be explained by a combination of natural genotype fluctuations and weaker natural and vaccine-induced immunity against infection with strains heterotypic to the vaccine, in the absence of significant variation in strain-specific vaccine effectiveness against disease. However, the incidence of rotavirus gastroenteritis is predicted to remain low despite vaccine-driven changes in the distribution of genotypes.
No takes yet. Share an insight, caveat, or question.
Pitzer et al. (2015) studied Rotavirus gastroenteritis. Large-scale rotavirus vaccination vs. Pre-vaccination period was evaluated on Rotavirus-related hospitalizations and genotype distribution. Large-scale rotavirus vaccination in Belgium led to an 85% decrease in rotavirus-related hospitalizations, with the subsequent predominance of G2P[4] infections explained by weaker immunity against heterotypic strains.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: